Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 39CNS 10Genitourinary 7Gynecologic 5Other solid neoplasm 4Gastrointestinal 4Lymphoid 3Dermatologic 3Thoracic 2Other hematologic neoplasm 2Myeloid 2Head & Neck 2Plasma cell 1Breast 1

Conditions

Small Cell Lung Carcinoma 156Lung Neoplasms 99Carcinoma, Non-Small-Cell Lung 61Extensive Stage Small Cell Lung Cancer 10Adenocarcinoma of Lung 7Parkinson Disease 4, Autosomal Dominant Lewy Body 5Carcinoma, Small Cell 5Adenocarcinoma, Bronchiolo-Alveolar 5Small Cell Lung Cancer Extensive Stage 4Drug-Related Side Effects and Adverse Reactions 4Small Cell Lung Cancer Limited Stage 3SCLC, Extensive Stage 3SCLC 3Recurrence 3Radiation Injuries 3Neoplasms 3Carcinoma, Ovarian Epithelial 3Thymoma 2Testicular Neoplasms 2Testicular Germ Cell Tumor 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2SCLC,Extensive Stage 2Ovarian Neoplasms 2Melanoma 2Limited Stage Small Cell Lung Cancer 2Kidney Neoplasms 2Extensive Small Cell Lung Cancer 2Carcinoma, Neuroendocrine 2Breast Neoplasms 2

Interventions

pembrolizumab 11Cyclophosphamide 8Gemcitabine 7Cisplatin 7tislelizumab 5Docetaxel 5Nivolumab 4Injections 4spartalizumab 3regorafenib 3Trastuzumab 3Oncolytic Virotherapy 3Irinotecan 3Filgrastim 3Drug Therapy 3Doxorubicin 3Carboplatin 3Bortezomib 3tazemetostat 2pazopanib 2liposomal doxorubicin 2ganitumab 2conatumumab 2belinostat 2Temozolomide 2Taxes 2Tamoxifen 2Sorafenib 2Riluzole 2Radiotherapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma × Etoposide × Thoracic × Clear all
NCT03420963 2026-03-20

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Terminated
12 enrolled
DermatologicGenitourinaryHead & NeckOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Bone Neoplasms, Endocrine Gland Neoplasms, Melanoma, Mouth Neoplasms, Pharyngeal Neoplasms, Sarcoma, Skin Neoplasms, Thyroid Neoplasms, Urologic Neoplasms

NCT00003657 2017-01-20

High-dose ICE With Amifostine

Dana-Farber Cancer Institute

Phase 2 Completed
24 enrolled
CNSGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Ovarian Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡